Celldex Therapeutics, Inc (CLDX) News

Latest headlines that mention CLDX, newest first · each headline opens the original publisher

CLDX quote

Last price: $29.67
Day change: +7.77%
Next earnings: 2026-11-09

Quote & chart Expected move Insider trading IV rank history

CLDX headlines

last 30 days

Seeking Alpha News 13d ago

Celldex Therapeutics: Trying To Put Its Troubled History Behind It

General T2CLDX

Investing.com 26d ago

Celldex Therapeutics Leads Guggenheim’s Biotechnology Rankings

General T3CLDX

Seeking Alpha News 27d ago

Celldex Therapeutics, Inc. (CLDX) Discusses Positive Phase 3 Results for Barzolvolimab in Chronic Spontaneous Urticaria Transcript

General T2CLDX

Seeking Alpha News 27d ago

Celldex Therapeutics, Inc. (CLDX) Discusses Positive Phase 3 Results for Barzolvolimab in Chronic Spontaneous Urticaria - Slideshow

General T2CLDX

Investing.com 27d ago

Why is Celldex Therapeutics stock sliding today?

General T3CLDX

Seeking Alpha 27d ago

Celldex falls after late-stage trial data for hives therapy

General T2CLDX

Reuters 27d ago

Celldex shares slip as safety concerns cloud skin drug trial win

General T1CLDX

CLDX news alerts

Get an alert by email or push when a new headline mentions CLDX.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.